Elevated levels of plasma cholesterol pose significant health risks and are causal to diseases including angina, cardiovascular disorders and diabetes. Although the long-term effect of elevated plasma cholesterol is known for its accretion in arterial walls, little is understood of its immediate effects. Since cholesterol levels in red blood cell (RBC) membranes are inversely associated with O 2 transport, and the RBC water channel AQP1 is also capable of transporting CO 2 , the detrimental effect of cholesterol on active water transport, and likely on the CO 2 and O 2 transport in RBC, was hypothesized and tested in the present study. The rapid gating of water into isolated rat RBC and the corresponding increase in their volume and surface area was determined using dynamic light scattering. Similarly, the entry of CO 2 into the RBC was determined using zeta potential measurements, as increase in intracellular acidity reduces the negative charge at the RBC membrane. Results from our study demonstrate for the first time that the immediate effect of elevated plasma cholesterol is dysfunction of active water and CO 2 transport, possibly via the AQP1 channel at the RBC membrane. Since there is growing evidence that PLA2 may play a key role in atherogenesis, and statins significantly reduce blood PLA2 levels, the effect of the PLA2 inhibitor on ameliorating the detrimental effects of cholesterol was investigated. Interestingly, the PLA2 inhibitor ONO-RS-082 was found to reverse the cholesterol effect on RBC function.
INTRODUCTION
Elevated levels of plasma cholesterol pose a significant health risk, and are causal to diseases including angina, cardiovascular disorders and diabetes, resulting in more than half a million deaths annually in the United States alone. Arterial plaque develops as a consequence of the long-term effects of high blood cholesterol (Cleeman et al. 2001) ; little is understood of its immediate effects. It is known that cholesterol in the blood plasma can rapidly enter and be incorporated into the red blood cell (RBC) membrane (Tall, 1993; Glomset et al., 1995; Ishizake et al., 1994) . Since the early to mid 1970s it has been demonstrated in human studies that the plasma and RBC membrane cholesterol levels are inversely associated with the transmembrane O 2 diffusion rate of RBC (Steinbach et al., 1974) . As blood cholesterol levels in the blood plasma and consequently in the RBC membrane decrease, blood oxygen diffusion into RBC increases (Steinbach et al., 1974; Menchaca et al., 2004) . The molecular mechanism, however, of this cholesterol effect has remained a mystery. In the early 1990s (Preston et al., 1992; Agre et al., 1993) , a protein channel called aquaporin-1 (AQP1), which actively transports water in RBC, was discovered. Subsequently, more than a dozen different types of aquaporin for active water transport in different tissues have been identified (King et al., 2004) . AQP1 is a 28 kDa polypeptide, which is present as a tetramer (Verbavatz et al., 1993) in the cell plasma membrane. Furthermore, AQPs have been found to be bidirectional (King et al., 2004) , suggesting that they are precisely regulated (Cho et al., 2002) . In support, the involvement of GTP-binding Gαi3 protein and PLA2 in the regulation of AQP1 function has been reported (Cho et al., 2002; Abu-Hamdah et al., 2004) . Earlier studies report the involvement of AQP1 in CO 2 transport. Studies expressing AQP1 in Xenopus oöcytes (Cooper, 1998) were the first to report that AQP1 could also be a CO 2 transporter, which was subsequently confirmed in studies in RBC (Blank, 2003) . In view of this, a detrimental rôle of cholesterol on water, CO 2 and O 2 transport through the RBC membrane was hypothesized, and the transport of water and CO 2 in the presence and absence of cholesterol was tested in the present study. Our results demonstrate that exposure of RBC to cholesterol is inhibitory to active water transport via aquaporins in that type of cell. Removal of cholesterol from RBC membrane using β-cyclodextran has little or no effect on water transport. Recent studies suggest an increase in PLA2 activity in macrophages of coronary lesions prone to rupture, and high PLA2 activity in response to osmotic pressure in cholesterol-containing vesicles. In view of this, the rôle of PLA2 in RBC water transport was investigated. Surprisingly, the PLA2 inhibitor ONO-RS-082 was able to reverse cholesterol's inhibitory effect on water transport in RBC, suggesting its potential use in the treatment of complications resulting from elevated blood cholesterol levels (Kolodgie et al., 2004; Okimasu et al., 1984) . Our study shows the immediate detrimental effect of cholesterol on RBC function, a major health risk that likely precedes angina, diabetes and cardiovascular disorders, including the eventual development of arterial plaque, as a consequence of the long term effects of high blood cholesterol. Since there is growing evidence that PLA2 may play a key rôle in atherogenesis, and statins significantly reduce blood PLA2 levels, the effect of the PLA2 inhibitor on ameliorating the detrimental effects of cholesterol prompts further study for its potential use as a drug.
MATERIALS AND METHODS
To investigate the possible immediate detrimental effect of high cholesterol on RBC water transport, RBC from rat blood were isolated for the study and their purity determined using both light microscopy and scanning electron microscopy (Fig. 1) . Both light and electron micrographs of the isolated RBC demonstrated an intact and homogeneous RBC preparation. Once the protocol for obtaining a pure RBC preparation was established, it was employed to isolate RBC for the present studies. To further confirm the purity of the isolated RBC used in the experiments, approximately 100 μL of the RBC preparation used in each experiment was fixed and saved for both light and electron microscopy. The presence of AQP1 and the regulatory components involved in its function at the RBC membrane was confirmed using immunoblot and immunoprecipitation assays (Fig. 2) . The interaction of regulatory proteins with AQP1 was further confirmed using immunofluoresence imaging of isolated RBC (Fig. 3) . To determine the rôle of cholesterol on AQP1-induced rapid gating of water into RBC, cholesterol was either added to isolated RBC or depleted from the RBC membrane using β-cyclodextrin (βCD), prior to mastoparan (Mas)-induced RBC swelling. The real-time changes in RBC size were determined using the established right-angle dynamic light scattering (DLS) method (Shin et al., 2010) , and further confirmed using light microscopy (Fig. 7) . Real-time changes in RBC size were determined using DLS in three separate experiments, each yielding 18 data points. To discount the effect of passive water transport, all DLS experiments to determine the relative size of RBC were carried out in water. Student's t-test was performed for comparison between groups, with significance established at P < 0.01. 
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Gα α α α αi3 PLA2 . Rapid water gating and consequent swelling of isolated RBC, impaired by high cholesterol and ameliorated by the PLA2 inhibitor ONO-RS-082. Note that both light and electron micrographs demonstrate the purity of the RBC preparation (Fig. 1) . Data represents percent of control from dynamic light scattering (DLS) experiments on isolated RBC in the presence of various modulators. Data from 2-3 experiments with 8-15 value points/experiment (* P < 0.01).
Isolation of rat red blood cells: Male SpragueDawley rats weighing 100-120 g were used for the study. Blood was collected by cardiac puncture immediately following CO 2 -induced euthanasia of the animal. The blood sample was diluted in 10 volumes of PBS, and spun at 120 g for 10 min at 4 °C. The resulting pellet was resuspended in 2 volumes of PBS and washed three times, followed by final resuspension in 10 volumes of PBS prior to use.
Light microscopy of rat red blood cells: 25 μL of isolated RBC were spread onto a glass slide. Cells were allowed to settle and stick to the surface of Cell-Takcoated slides at room temperature, and the unattached cells thrice gently rinsed using 200 μL of PBS. Cells were imaged using a Zeiss Axiovert microscope (100×objective).
Scanning electron microscopy of rat red blood cells: 25 μL of isolated RBC were spread onto 13 mm Thermonox cover slips coated with 0.2% poly-L-lysine. Cells were allowed to settle and stick to the surface of the coverslip at 4 °C, and the excess sample rinsed gently by dipping into 4 changes of Milli Q ultrapure water. The cover slips were loaded into a cylindrical holder and dehydrated for 5 min each in increasing concentrations of ethanol (35, 50, 70, 85 and 95%) followed by four 5 min washes in 100% ethanol. The sample was critical-point dried and mounted onto one large aluminum specimen stub in puddles of liquid graphite, sputter coated with gold and palladium and imaged with a JSM 6060 scanning electron microscope at 25 kV, spot size 30, WD ~ 6 mm at various magnifications up to 28 000× (Fig. 1) .
Western blot analysis and immunoisolation of AQP1-associated proteins at the RBC membrane: Isolated RBC were lysed using sonication and centrifuged for 1 h at 100 000 g to obtain the cell plasma membrane. The RBC plasma membrane was obtained as a pellet, solubilized using 1% w/v Triton-Lubrol mixture and mixed in 1 × Laemmli sample preparation buffer, prior to one-dimensional 10% SDS-PAGE, electrotransfer to nitrocellulose and immunoblot analysis using specific antibodies to AQP1 (Santa Cruz Biotechnology Inc., Santa Cruz, California). To immunoisolate the RBC-membrane AQP1 and associated proteins, the 1% w/v TritonLubrol-solubilized RBC membrane was immunoisolated using the specific antibodies to AQP1 conjugated to protein G-Sepharose beads (Santa Cruz Biotechnology). The resultant immunoisolates was resolved using 10% SDS-PAGE, electrotransfer to nitrocellulose and immunoblot using G αi3 and PLA2-specific antibody (Fig. 2) .
Immunocytochemistry: Isolated RBC were fixed in ice-cold 4% paraformaldehyde in 0.01 M phosphatebuffered saline (PBS, pH 7.4) for 20 min, washed twice in 0.01 M PBS (pH 7.4), and incubated for 30 min at room temperature in blocking buffer (5% nonfat milk in PBS containing 0.1% Triton X-100 and 0.02% NaN 3 ). Cells were incubated for 1 h at room temperature with 1:200 primary antibody dilutions in PBS-0.1% Triton X-100 and 0.02% NaN 3 (AQP1 and G αi3 , Santa Cruz Biotechnology). After washing with PBS-0.1% Triton X-100 and 0.02% NaN 3 , the mixture of Alexa Fluor 488-conjugated donkey anti-goat IgG and Alexa Fluor 594-conjugated donkey anti-rabbit (Molecular Probes Inc., Eugene, Oregon) was used as secondary antibody (1/500 dilution) for 1 h at room temperature. Cells were then washed with PBS containing 0.1% Triton X-100 and 0.02% NaN 3 followed by washing in PBS buffer, and examined using a Leica AE 6000 confocal microscope with a 63×objective (final magnification 1620×).
Dynamic light scattering of RBC: Measurements of RBC size dynamics were determined using realtime, right-angle light scattering in a Hitachi F-2000 spectrofluorimeter. Real-time scattered light intensities at excitation and emission wavelengths of 530 nm were used to measure the size dynamics of RBC (Shin et al., 2010) . In these experiments, isolated RBC were suspended in water, and rapid changes in their size were monitored before and after addition of HgCl 2 (AQP1 inhibitor), PLA2 inhibitor (ONO-RS-082), cholesterol (CHOL), or β-cyclodextrin (cholesterol removal from membranes), followed by mastoparan exposure. Mastoparan (Mas) is an amphiphilic tetradecapeptide from wasp venom that stimulates Gαi3/Gαo proteins by promoting the GTPase activity of the G protein (Cho et al., 2002) . Results were expressed as the percent light scattered compared with the controls. Student's t-test was performed for comparison between groups, with significance established at P < 0.05.
Cholesterol reconstitution into the RBC membrane: To determine whether exposure of RBC to cholesterol results in the incorporation of cholesterol into the RBC membrane, cholesterol was measured in the RBC plasma membrane following incubation in cholesterol for various intervals. Following incubation of RBC for 0, 10, 20 and 30 min in buffer containing 40 μM cholesterol, the cells were lysed using sonication and centrifuged for 1 h at 100 000 g to obtain the cell plasma membrane. The RBC plasma membrane, obtained as a pellet, was solubilized using 1% w/v Triton-Lubrol mixture, and assayed for cholesterol and protein content. Cholesterol content was measured using an Amplex Red Cholesterol Assay Kit (Molecular Probes) according to the manufacturer's instructions. Protein concentrations were assayed using the Pierce BCA protein assay kit (Thermo Scientific, Rockford, Illinois) (Smith et al., 1985) .
Determination of the optimal dose of various compounds used in the regulation of RBC swelling due to rapid water entry: Dose-response experiments to determine the effects of various compounds on RBC volume were performed using dynamic light scattering (DLS). Optimal doses of the water channel stimulator mastoparan (Mas), the water channel inhibitor HgCl 2 , the PLA2 inhibitor ONO-RS-082, cholesterol (CHOL) and the cholesterol-depleting agent β-cyclodextrin were determined (Smith et al., 1985) .
Zeta potential measurements of RBC surface charge, before and following exposure to cholesterol and carbon dioxide: The surface charge of the RBC was measured via their zeta potential using a Malvern Instruments Zetasizer. Normally, membranes are negatively charged; however, if carbon dioxide were to enter the cell, the carbonic acid generated within the RBC would tend to neutralize the net negative charge of the RBC membrane. The more CO 2 enters, the more positive the membrane potential of the RBC membrane. This assay therefore was designed to determine the effect of cholesterol on the entry of CO 2 into RBC.
RESULTS AND DISCUSSION
The cholesterol incorporation studies demonstrated the incorporation of exogenous cholesterol into the RBC membrane, with maximal incorporation following 30 min of incubation (Fig. 4) . The optimal dose of the various compounds to be used in the main study was determined (Fig. 5) . The results demonstrated that 40 μM mastoparan (Mas) is able to maximally stimulate rapid water entry into RBC compared with the control, as demonstrated using dynamic light scattering (DLS). Similarly, exposure of RBC to various concentrations of the water channel blocker HgCl 2 demonstrates that 300 μM HgCl 2 maximally inhibits rapid water gating into RBC. As hypothesized, cholesterol (CHOL) was found to maximally inhibit RBC water gating at a concentration of 40 μM. Removal of cholesterol from the RBC membrane was found to be most effective using 40 μM β-cyclodextrin. Furthermore as hypothesized, the PLA2 inhibitor ONO-RS-082 potentiated RBC swelling, with maximal effect at 20 μM, and was able to lessen the detrimental effects of cholesterol on RBC water entry (Fig. 6) . To further confirm the effect of cholesterol on water transport through the AQP1 at the RBC membrane, mastoparan-induced RBC swelling experiments were performed and observed using light microscopy (Fig. 7) . Results from this study further confirmed the DLS results that mastoparan-induced water transport into RBC is inhibited in the presence of HgCl 2 and cholesterol. Next, the rate of water entry was assessed under various incubation conditions; results are presented in Fig. 8 . During the course of the study, no changes in RBC size were detected when they were placed in water. However, exposure of RBC in water to 40 μM mastoparan (Mas), resulted in a 57% (Figs 6 and 8) ) of Mas-induced RBC swelling. These results demonstrate for the first time that although cholesterol is critical for the integrity and function of the RBC membrane, excess cholesterol is detrimental to AQP1 function regarding the rapid transport of water and possibly the transport of both CO 2 and O 2 through the channel [5, 14] . These results reveal a further immediate detrimental effect of cholesterol on RBC function. Since plasma cholesterol is known to be rapidly incorporated into the membrane of circulating RBC and our studies confirm this (Fig. 4) , the immediate detrimental effects of blood cholesterol levels on RBC function were accordingly demonstrated from this study.
Since the PLA2 inhibitor ONO-RS-082 results in rapid (k = 0.077 s -1 ) potentiation (262.2 ± 45.5) of RBC swelling, and since there is growing evidence that PLA2 may play a key rôle in atherogenesis, and statins significantly reduce blood PLA2 levels, the effect of the PLA2 inhibitor on ameliorating the detrimental effects of cholesterol-induced defects on RBC water entry was investigated. Exposure of the dysfunctional cholesterolexposed RBC to ONO-RS-082 resulted in the amelioration of the potency (from 18.89 ± 5.62 to 146.89 ± 6.62) of Mas-induced RBC swelling (Figs 6 and 8) . Surprisingly, no change in rapidity (k = 0.026 s -1 vs k = 0.027 s -1 ) of Mas-induced RBC swelling (Figs 6 and 8) was observed in the dysfunctional cholesterol-exposed RBC following ONO-RS-082 exposure. These studies demonstrate that although ONO-RS-082 could potentially be used for the treatment of RBC dysfunction due to elevated plasma cholesterol, a more potent drug should be sought. They further demonstrate that a major health risk, which likely precedes angina, diabetes and cardiovascular disorders, including the eventual development of arterial plaque, as a consequence of the long-term effects of high blood cholesterol, is AQP1 dysfunction in the RBC, resulting in defects in water, and likely CO 2 and O 2 , transport. To further determine the effect of high cholesterol on RBC function, the transport of gases through the RBC membrane was determined (Fig. 9) . Cell membranes are normally negatively charged; however, when carbon dioxide enters the cell, the carbonic acid generated within it results in neutralization of the net negative charge of the RBC membrane. The more CO 2 that enters, the more positive the membrane potential of the RBC membrane.
Results from our study demonstrate that an increase in RBC membrane cholesterol is detrimental to CO 2 entry into RBC, as demonstrated in the near abolition of RBC membrane charge neutralization compared to the control RBC. 
SUMMARY AND CONCLUSIONS
Our study demonstrates the immediate detrimental effect of cholesterol on RBC function, a major health risk that likely precedes angina, diabetes and cardiovascular disorders, including the eventual development of arterial plaque, as a consequence of the long-term effects of high blood cholesterol. Furthermore, the PLA2 inhibitor ONO-RS-082 was able to ameliorate high cholesterol effects on RBC function, and could potentially be used as a drug for the treatment of RBC dysfunction due to elevated plasma cholesterol.
